Magrath George
Magrath George, CEO, reported a transaction classified as exercise at Opus Genetics, Inc. involving 392157.000000 shares for an estimated $450980.55. Reported holdings after the transaction were 2124026.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
- Trade date
- Sep 09, 2026
- Filing date
- Sep 11, 2026
How reported position traded is calculated
Calculated only for code-P purchases and code-S sales.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
IRD price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- exercise Code M
- Identifier
- 0001140361-26-036347 Common Stock
- Transaction date
- Sep 09, 2026 Filed Sep 11, 2026, 08:09 PM · 2d delay
- Shares
- 392,157 sh $1.15 per share
- Estimated value
- $450k Computed from shares × price
- Holdings after
- 2,124,026 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
+10 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - timely_filing+4 points
reporting_delay_days = 2
Filing reported within two business days of the transaction.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
Chief Executive Officer
- F1
The Reporting Person paid the exercise price of the Warrant on a cashless basis. The Issuer withheld 75,541 shares, calculated in accordance with the terms of the Warrant, to pay the exercise price a…
- F2
The Warrant was immediately exercisable upon its acquisition on March 24, 2025, subject to the Issuer's right to call the Warrant at any time beginning 30 days following the release of the Issuer's OP…
0 other transactions
0 recent txs